Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001027-11Phase 4Terminated
Phase 4, randomised, open-label trial of metformin and gliclazide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Primary endpoints: Adverse drug effect rates, Withdrawal from active treatment due to adverse effects and 1 more. Started May 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001027-11.